Cardiovascular Disease

Starting Oct. 13, Emory University will host its 25th Cardiology in Primary Care Conference, a 2.5-day event that will provide information on the outpatient management of cardiac conditions.

Effective facilitators in primary care settings helped practices to think more critically and motivated them to support change, resulting in significant improvements in preventive CVD care, a recent study found.

The American Association of Clinical Endocrinology has updated its guidance for diabetes care, which include 170 new and updated recommendations on prevention, diagnosis and treatment.

New data have linked more consistent use of CPAP treatment to lower risk for rehospitalization in older adults with obstructive sleep apnea and cardiovascular disease.

Anemia independently correlated with lower eGFR and an increased risk of end-stage kidney disease, cardiovascular disease, coronary heart disease, stroke, heart failure and death, according to recently published data.

Low-dose aspirin for primary prevention of CV events may benefit older adults with elevated lipoprotein(a)-associated genotypes, according to a new analysis of the ASPREE trial.

Cannabinoids are widely available for therapeutic and recreational use, but data are limited regarding drug-drug interactions — particularly with cardiovascular medications, according to experts.

Being diagnosed with type 2 diabetes at age 40 years or younger is associated with higher risks for mortality and cardiovascular disease, according to a presenter at the European Association for the Study of Diabetes annual meeting.

Greater consumption of artificial sweeteners was associated with a higher risk for cardiovascular, cerebrovascular and coronary heart disease, a study published in the BMJ found.

Due to a significant association between the urine to phosphate-to-creatinine ratio and mortality among individuals without chronic kidney disease, researchers suggest this may be a predictor for future adverse events in this population.